Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Nuvasive Inc (NUVA)

Nuvasive Inc (NUVA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 3,154,992
  • Shares Outstanding, K 51,284
  • Annual Sales, $ 1,168 M
  • Annual Income, $ 65,230 K
  • 60-Month Beta 1.33
  • Price/Sales 2.94
  • Price/Cash Flow 12.20
  • Price/Book 3.34
Trade NUVA with:

Options Overview

Details
  • Implied Volatility 45.62%
  • Historical Volatility 26.68%
  • IV Percentile 2%
  • IV Rank 14.20%
  • IV High 166.86% on 03/16/20
  • IV Low 40.94% on 08/11/20
  • Put/Call Vol Ratio 0.32
  • Today's Volume 62
  • Volume Avg (30-Day) 290
  • Put/Call OI Ratio 0.26
  • Today's Open Interest 1,851
  • Open Int (30-Day) 2,441

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 17 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/21
See More
  • Average Estimate 0.41
  • Number of Estimates 7
  • High Estimate 0.48
  • Low Estimate 0.33
  • Prior Year 0.48
  • Growth Rate Est. (year over year) -14.58%

Price Performance

See More
Period Period Low Period High Performance
1-Month
53.50 +13.51%
on 02/03/21
62.47 -2.79%
on 03/01/21
+6.62 (+12.23%)
since 02/02/21
3-Month
44.80 +35.56%
on 12/10/20
62.47 -2.79%
on 03/01/21
+13.83 (+29.49%)
since 12/02/20
52-Week
28.55 +112.71%
on 03/18/20
67.70 -10.30%
on 06/08/20
-4.90 (-7.47%)
since 03/02/20

Most Recent Stories

More News
Spinal Fusion Devices Market Size Worth USD 8.90 Billion by 2027 | The Advancements in Surgical Technology and Rising Demand for Minimally Invasive Spine Surgeries are Significant Factors Influencing Industry Growth, says Emergen Research

The global Spinal Fusion Devices Market will be worth USD 8.90 Billion by 2027, according to a current analysis by Emergen Research. The growth of this market can be attributed to the increasing advancements...

ATEC : 16.81 (+1.63%)
EXAC : 49.25 (unch)
FSNN : 0.0580 (-19.44%)
GMED : 62.30 (-0.61%)
MDT : 117.87 (+0.01%)
NUVA : 60.73 (-1.28%)
OFIX : 45.74 (-1.99%)
SYK : 245.39 (-0.17%)
NuVasive (NUVA) Boosts Cervical Portfolio With New Buyout

NuVasive (NUVA) expands comprehensive portfolio of C360 with the addition of Simplify Disc.

OMI : 33.00 (-3.34%)
VIVO : 21.50 (-2.54%)
NUVA : 60.73 (-1.28%)
NVST : 39.38 (-0.23%)
NuVasive's (NUVA) Q4 Earnings Top Estimates, Margin Declines

NuVasive (NUVA) registers strong international performance in Q4 along with continued adoption of advanced material science implants in the U.S. Spinal Hardware business.

HOLX : 74.82 (+0.24%)
ABT : 122.53 (+0.26%)
NUVA : 60.73 (-1.28%)
IDXX : 529.47 (-1.62%)
NuVasive Announces Fourth Quarter and Full Year 2020 Financial Results

, /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced...

NUVA : 60.73 (-1.28%)
NuVasive, Inc. to Host Earnings Call

NEW YORK, NY / ACCESSWIRE / February 25, 2021 / NuVasive, Inc. (NASDAQ:NUVA) will be discussing their earnings results in their 2020 Fourth Quarter Earnings call to be held on February 25, 2021 at 4:30...

NUVA : 60.73 (-1.28%)
NuVasive Acquires Simplify Medical

, /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced...

NUVA : 60.73 (-1.28%)
NuVasive to Present at the 41st Annual Cowen Health Care Conference

, /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced...

NUVA : 60.73 (-1.28%)
NuVasive Announces Conference Call and Webcast of Fourth Quarter and Full Year 2020 Results

, /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced...

NUVA : 60.73 (-1.28%)
NuVasive Expands Clinical Professional Development Program with New East Coast Experience Center in New York Metropolitan Area

, /PRNewswire/ -- NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced...

NUVA : 60.73 (-1.28%)
Orthopedic Devices Market 2021 Size & Share | Market worth USD 71.67 Billion with 4.3% CAGR by 2026

The global orthopedic devices market is set to gain traction from the ever-increasing geriatric population across the world. As per a research published in 2015 by the United Health Foundation, every year,...

GMED : 62.30 (-0.61%)
MDT : 117.87 (+0.01%)
NUVA : 60.73 (-1.28%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Strongest short term outlook on maintaining the current direction.

See More Share

Business Summary

NuVasive, Inc. is transforming spine surgery and beyond with minimally invasive, procedurally-integrated solutions designed to deliver reproducible and clinically-proven surgical outcomes. The Company's portfolio includes access instruments, implantable hardware, biologics, and software systems for surgical...

See More

Key Turning Points

3rd Resistance Point 63.64
2nd Resistance Point 62.81
1st Resistance Point 61.77
Last Price 60.73
1st Support Level 59.90
2nd Support Level 59.07
3rd Support Level 58.03

See More

52-Week High 67.70
Last Price 60.73
Fibonacci 61.8% 52.74
Fibonacci 50% 48.13
Fibonacci 38.2% 43.51
52-Week Low 28.55

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar